Loading...
The University of Chicago Header Logo
Keywords
Last Name
Institution

Adalimumab for maintenance treatment of Crohn's disease: results of the CLASSIC II trial.

Sandborn WJ, Hanauer SB, Rutgeerts P, Fedorak RN, Lukas M, MacIntosh DG, Panaccione R, Wolf D, Kent JD, Bittle B, Li J, Pollack PF. Adalimumab for maintenance treatment of Crohn's disease: results of the CLASSIC II trial. Gut. 2007 Sep; 56(9):1232-9.

View in: PubMed

collapse authors with profiles